RankAlpha logo
Back to Rankings

PRLD

Prelude TherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
Current thesis
The bull case is that PRLD has turned its strategic reset into visible execution: PRT12396 is in Phase 1, PRT13722 remains on track for a mid-2026 IND and 2H 2026 initiation, and cash now extends into Q2 2028 after the May financing [#SEC-8K-2026-05-12] [#10-K-2026-03-10]. That creates multiple shots on goal without a near-term financing spiral.
Posture
Defensive
Lead driver
Momentum
What changed
News driver: Insider Buying : Prelude Therapeutics ( NASDAQ : PRLD ) Director Acquires 2 , 815 , 315 Shares of Stock.
What can break
Coverage is thin; the post-print analyst revisions are informative but not yet a durable validation signal [#PR-EARNINGS-2026-05-16].
Momentum
81
Value
41
Sentiment
30
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $3.50 · Bull $6.25 · Bear $1.50
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-06-03 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $8.00
Why
Momentum81 · Δ7d -5.4
Value41 · Δ7d -0.1
Sentiment30 · Δ7d +8.0
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Momentum · See technicals
Momentum
81
26% active weight
Current posture
7d trendFlat
Δ7d
-5.4
Δ21d
+11.6
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
0.0
Sentiment
30
34% active weight
Current posture
7d trendImproving
Δ7d
+8.0
Δ21d
+1.7
Why this grade

Composite grade D. Momentum 81.4 / Value 41.1 / Sentiment 29.6

Fundamentals (TTM)
As of 2026-07-17
Market Cap
$334.51M
Beta
0.88
Shares Out
79.65M
P/E (TTM) · Derived
-3.2
P/S (TTM)
14.61
P/FCF (TTM) · Derived
-8.57
Rev YoY
+41.0%
EPS YoY
-70.2%
Gross Margin
+90.0%
Op Margin
-1152.8%
Net Debt
-$85.43M
Current Ratio
2.03
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology